Skip to main content
. 2019 Dec 30;2019:5049245. doi: 10.1155/2019/5049245

Figure 2.

Figure 2

(a) Representative gating strategy of each cell population of CD4 effector T cells. (b) Representative gating strategy of each cell population of regulatory cells of a DLE patient. Percentages of circulating (c) CD4+/CD161−/IL-22+ cells, (d) CD4+/CD161+/IL-17A+ cells, (e) CD4+/CD25−/IL-4+ cells, (f) CD4+/CD25−/IFN-γ+ cells, (g) CD4+/CD25hi/Foxp3+ cells, (h) CD19+/CD38hi/IL-10+ cells, and (i) CD123+/CD196+/IDO+ cells. The results are expressed as the mean (horizontal yellow line), median (horizontal black line), and 5th/95th percentiles ∗P < 0.05 and ∗∗P < 0.001. SCLE: subacute cutaneous lupus erythematosus; DLE: discoid lupus erythematosus; HD: healthy donors.